Ultrasound-guided nonviral gene therapy.

Harnessing microbubbles for the targeted delivery of genetic medicines to a wide range of human organs.

SonoThera is developing an ultrasound-guided nonviral gene therapy platform and therapies to provide patients with the next generation of genetic medicines.

Meet gene therapy for the 21st century

Delivery

Non-invasive targeted delivery to most organs.

Safety

Our technology uses ultrasound microbubbles and hardware with an established safety track record.

Versatility

A diversity of nucleic acid payloads of large size may be delivered.

SonoThera’s technology platform aims to overcome the most significant barriers in gene therapy such as safety, efficacy, biodistribution, and high costs of goods.

Read all about it! See us in the news and visit our blog for the latest in gene therapy

Learn more about SonoThera

See how SonoThera’s platform technology unlocks gene therapy

Would you like to know how SonoThera came about?

Meet our team, uniquely qualified to develop next-generation gene therapies

Come build the future of gene therapy with us

Sonoporation has successfully been used preclinically and in the clinic

Learn more about our platform

Read all about it! See us in the news and visit our blog for the latest in gene therapy.

Learn more about SonoThera.

Come build the future of gene therapy with us.

See how SonoThera’s platform technology unlocks gene therapy.

Would you like to know how SonoThera came about?

Sonoporation has successfully been used preclinically and in the clinic.

Meet our team, uniquely qualified to develop next-generation gene therapies.

Learn more about our platform.